Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

Oral VRL offers easier administration, better quality of life, and cost saving. This study aimed to evaluate the treatment efficacy in terms of tumor response of the two formulations of vinorelbine (VRL, oral and IV) in combination with epirubicin (EPI); and the effect of EPI co-administration on VR...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Chemother Pharmacol
Autori principali: Huang, Liang, Wang, Xiaojia, Zhou, Liheng, Di, Lijun, Zheng, Hongyu, Jiang, Zefei, Wang, Yongsheng, Song, Xiangqun, Feng, Jifeng, Yu, Shiying, Liu, Yunpeng, Zheng, Hong, Shen, Kunwei, Tong, Zhongsheng, Shao, Zhimin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://ncbi.nlm.nih.gov/pubmed/31838561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-04000-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi